Listen "How are the 2025 ESC/EACTS valvular guidelines going to impact my mitral programme?"
Episode Synopsis
Francesco Maisano interviews Michael Borger, co-chair of the 2025 ESC/EACS valvular heart disease guidelines, on their practical impact. The updated guidelines emphasize earlier intervention in primary mitral regurgitation, especially for asymptomatic patients with risk factors, while surgery remains preferred for low-risk patients. Michael Borger stresses the importance of a multidisciplinary team approach, high-volume centres for complex cases, and timely, evidence-based interventions to improve patient outcomes. Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast PCR Perspectives
The D-PACE scoring system - Can we predict high-grade conduction disturbances after TAVI?
04/12/2025
How are the new 2025 ESC/EACTS valvular guidelines going to impact my tricuspid programme?
21/11/2025
What are the essentials of the provisional strategy for non-left main true bifurcation lesions?
13/11/2025
EuroPCR 2025 Hotline - ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis
06/11/2025
What is the latest in DCB practice?
30/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.